A 58-year-old woman with a 15-year history of poorly controlled hypertension (BP 175/115 mmHg) presents with sudden loss of vision in the left eye over 2 days. On examination, she has acute papilledema with blurred disc margins, Elschnig spots, and Paton's lines. Fundoscopy also reveals flame hemorrhages, cotton-wool spots, and a macular star exudate pattern. Serum creatinine is 2.8 mg/dL (baseline 0.9 mg/dL). What is the most appropriate immediate management?

Explanation

## Malignant Hypertensive Retinopathy: Emergency Management **Key Point:** This patient has Grade IV (malignant) hypertensive retinopathy with acute papilledema, Elschnig spots, Paton's lines, and acute renal dysfunction (elevated creatinine). This is a **hypertensive emergency** requiring immediate IV antihypertensive therapy, NOT oral agents or topical measures. ### Diagnostic Criteria for Malignant Hypertension | Feature | Present in This Case | |---------|----------------------| | BP > 180/120 mmHg | ✓ (175/115) | | Acute papilledema | ✓ | | Retinal hemorrhages & exudates | ✓ | | Acute end-organ damage (renal, cardiac, neurologic) | ✓ (Cr 2.8 mg/dL) | | Elschnig spots or Paton's lines | ✓ | **High-Yield:** Malignant hypertension is defined by the presence of **acute end-organ damage** (not just BP level). The acute rise in creatinine indicates acute kidney injury (acute tubular necrosis or hemolytic uremic syndrome). Elschnig spots (retinal whitening from arteriolar necrosis) and Paton's lines (circumferential retinal folds) are pathognomonic for Grade IV retinopathy. ### Immediate Management Algorithm ```mermaid flowchart TD A[Malignant Hypertension Suspected]:::urgent --> B{Acute End-Organ Damage?}:::decision B -->|Yes| C[Hypertensive Emergency]:::urgent C --> D[IV Antihypertensive Agent]:::action D --> E[Target: Reduce BP 25% in 1 hour]:::action E --> F[Agents: Labetalol, Nitroprusside, Nicardipine]:::action F --> G[Continuous Monitoring: BP, HR, Urine Output]:::action G --> H[Urgent Nephrology & Cardiology Consult]:::action H --> I[Transition to Oral Agents Once Stable]:::action B -->|No| J[Hypertensive Urgency]:::outcome J --> K[Oral Agents Acceptable]:::action ``` **Clinical Pearl:** The goal in hypertensive emergency is **controlled reduction** of BP by 10–25% in the first 1–2 hours, then gradual reduction to 160/100 mmHg over 2–6 hours. Overly rapid BP reduction risks stroke, MI, or acute coronary syndrome due to loss of cerebral/coronary autoregulation. **Mnemonic:** **LINEN** for IV agents in hypertensive emergency — **L**abetalol, **I**soniazid (no—use **N**itroprusside), **N**icardipine, **E**nalapril (IV), **N**itroglycerin. Labetalol and nitroprusside are first-line. ### Why Labetalol or Nitroprusside? 1. **Labetalol** (alpha + beta blocker): Reduces BP smoothly, preserves cerebral/renal perfusion, safe in pregnancy and renal disease. 2. **Sodium nitroprusside** (direct vasodilator): Rapid onset, titratable, but requires ICU monitoring and risk of cyanide toxicity with prolonged use (>4 hours). 3. **Nicardipine** (dihydropyridine CCB): Alternative IV agent; slower onset than nitroprusside. **Warning:** Avoid rapid-acting oral agents (e.g., immediate-release nifedipine) in acute hypertensive emergencies—risk of unpredictable, uncontrollable BP drops and stroke.